hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes

I Le Ber, I Van Bortel, G Nicolas, K Bouya-Ahmed… - Neurobiology of …, 2014 - Elsevier
I Le Ber, I Van Bortel, G Nicolas, K Bouya-Ahmed, A Camuzat, D Wallon, A De Septenville…
Neurobiology of aging, 2014Elsevier
Abstract hnRNPA2B1 and hnRNPA1 mutations have been recently identified by exome
sequencing in three families presenting with multisystem proteinopathy (MSP), a rare
complex phenotype associating frontotemporal lobar degeneration (FTLD), Paget disease of
bone (PDB), inclusion body myopathy (IBM), and amyotrophic lateral sclerosis (ALS). No
study has evaluated the exact frequency of these genes in cohorts of MSP or FTD patients
so far. We sequenced both genes in 17 patients with MSP phenotypes, and in 60 patients …
Abstract
hnRNPA2B1 and hnRNPA1 mutations have been recently identified by exome sequencing in three families presenting with multisystem proteinopathy (MSP), a rare complex phenotype associating frontotemporal lobar degeneration (FTLD), Paget disease of bone (PDB), inclusion body myopathy (IBM), and amyotrophic lateral sclerosis (ALS). No study has evaluated the exact frequency of these genes in cohorts of MSP or FTD patients so far. We sequenced both genes in 17 patients with MSP phenotypes, and in 60 patients with FTLD and FTLD-ALS to test whether mutations could be implicated in the pathogenesis of these disorders. No disease-causing mutation was identified. We conclude that hnRNPA2B1 and hnRNPA1 mutations are rare in MSP and FTLD spectrum of diseases, although further investigations in larger populations are needed.
Elsevier